The first amendment to the WTO TRIPS Agreement permits compulsory licensing for pharmaceutical exports to countries lacking manufacturing capacity. India implemented this provision through Section 92A of its Patents Act, reinforcing its commitment to global public health.
Read more about First Amendment to WTO comes into forceTag: WTO TRIPS
Extension of Waiver for Pharma Patents until 2033 A.D.
The WTO has extended the waiver on pharmaceutical patent enforcement for least developed countries until 2033. This move ensures continued access to affordable generics from India and highlights the ongoing tension between patient access and patent rights.
Read more about Extension of Waiver for Pharma Patents until 2033 A.D.OCR: Credibility of India’s Intellectual Property Enforcement in Question
The US Trade Representative’s review has raised concerns about India’s intellectual property enforcement standards. Indian officials contest the review’s legitimacy and stress that their IP laws prioritise public interest. The results may impact India’s investment climate and global image.
Read more about OCR: Credibility of India’s Intellectual Property Enforcement in Question